Adaptive Biotechnologies Corporation · NASDAQ:ADPT

Rubinstein Julie sold 69,061 Adaptive Biotechnologies Corporation shares (Form 4)

Traded Apr 6 to Apr 8, 2026 · Filed Apr 8, 2026

From Apr 6 to Apr 8, 2026, Rubinstein Julie (President and COO) sold 69,061 Adaptive Biotechnologies Corporation shares at an average US$14.34 for US$991K under a trading plan, leaving 434,188 shares. Filed Apr 8, 2026 (Form 4).

Sold
69,061 shares
Price
US$14.34 average (US$13.56 to US$15.48)
Value
US$991K
Holding after
434,188 shares
Trading plan
Yes (Made under a plan set in advance)
Role
President and COO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 6, 2026Common StockOption exercise14,722US$7.27461,924Direct
Apr 6, 2026Common StockSale19,060US$14.33442,864Direct
Apr 7, 2026Common StockOption exercise14,722US$7.27457,586Direct
Apr 7, 2026Common StockSale19,060US$13.56438,526Direct
Apr 8, 2026Common StockOption exercise14,722US$7.27453,248Direct
Apr 8, 2026Common StockOption exercise11,881US$12.14465,129Direct
Apr 8, 2026Common StockSale30,841US$14.83434,288Direct
Apr 8, 2026Common StockSale100US$15.48434,188Direct

Source

View original at SEC

Related